Thanks 202020,
You have referred to this source:
http://www.chinadaily.com.cn/bizchina/2009-11/16/content_8975738.htm
GSK is CONSIDERING investing in a manufacturing facility to produce Relenza for the country, said the GSK's Reilly, declining to elaborate.
What is the chance of GSK manufacturing in China when in 2006 they licensed Simcere but did not provide the know-how to manufacture Relenza and Simcere said it will take a long time for approval?
"Test procedures for the drug Zanamivir are still being decided. It would take a long time to complete the clinical trials," said Xu Xiaoping, a member of the institute
http://news.xinhuanet.com/english/2009-02/06/content_10772564.htm
By the time the tests are completed and manufacturing commence, what is left of the Relenza patent? Chi-Renza - the Chinese version of the Indian Virenza.
- Forums
- ASX - By Stock
- BTA
- resistance
resistance, page-15
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online